ES2155515T3 - Derivados de difluorostatona macrociclica utiles como agentes antivirales. - Google Patents
Derivados de difluorostatona macrociclica utiles como agentes antivirales.Info
- Publication number
- ES2155515T3 ES2155515T3 ES95903633T ES95903633T ES2155515T3 ES 2155515 T3 ES2155515 T3 ES 2155515T3 ES 95903633 T ES95903633 T ES 95903633T ES 95903633 T ES95903633 T ES 95903633T ES 2155515 T3 ES2155515 T3 ES 2155515T3
- Authority
- ES
- Spain
- Prior art keywords
- useful
- hiv
- antiviral agents
- derivatives
- macrociclica
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003443 antiviral agent Substances 0.000 title abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 2
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 108700022715 Viral Proteases Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001177 retroviral effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA PRESENTE INVENCION PROPORCIONA NUEVOS DERIVADOS DE DIFLUOROSTATONA MACROCICLICA QUE SON UTILES COMO AGENTES ANTIVIRALES. MAS ESPECIFICAMENTE, ESTOS NUEVOS COMPUESTOS SON UTILES COMO INHIBIDORES DE PROTEASAS RETROVIRALES REQUERIDAS PARA LA REPRODUCCION, PARTICULARMENTE LAS PROTEASAS VIRALES HIV-1 Y HIV-2, EN LA PREVENCION O TRATAMIENTO DE LA INFECCION POR EL VIRUS DE INMUNODEFICIENCIA HUMANA (HIV), Y EN EL TRATAMIENTO DE LAS CONSIGUIENTES CONDICIONES PATOLOGICAS TALES COMO EL SINDROME DE INMUNODEFICIENCIA ADQUIRIDA (SIDA) EN MAMIFEROS CAPACES DE SER INFECTADOS CON EL VIRUS DEL VIH.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19208094A | 1994-02-04 | 1994-02-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2155515T3 true ES2155515T3 (es) | 2001-05-16 |
Family
ID=22708156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES95903633T Expired - Lifetime ES2155515T3 (es) | 1994-02-04 | 1994-11-28 | Derivados de difluorostatona macrociclica utiles como agentes antivirales. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5969132A (es) |
| EP (1) | EP0742791B1 (es) |
| JP (1) | JP3574455B2 (es) |
| KR (1) | KR100367379B1 (es) |
| CN (1) | CN1142830A (es) |
| AT (1) | ATE198602T1 (es) |
| AU (1) | AU684875B2 (es) |
| CA (1) | CA2182476C (es) |
| DE (1) | DE69426574T2 (es) |
| DK (1) | DK0742791T3 (es) |
| ES (1) | ES2155515T3 (es) |
| FI (1) | FI963073A0 (es) |
| GR (1) | GR3035623T3 (es) |
| HU (1) | HUT74384A (es) |
| IL (1) | IL112514A0 (es) |
| NO (1) | NO963254L (es) |
| NZ (1) | NZ277410A (es) |
| PT (1) | PT742791E (es) |
| WO (1) | WO1995021186A1 (es) |
| ZA (1) | ZA95756B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE457995T1 (de) | 2003-06-18 | 2010-03-15 | Tranzyme Pharma Inc | Makrozyklische motilin rezeptorantagonisten |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH672792A5 (es) * | 1985-02-19 | 1989-12-29 | Sandoz Ag | |
| WO1986006379A1 (en) * | 1985-04-19 | 1986-11-06 | The Upjohn Company | Dihalo-statine substituted renin inhibitors |
| WO1990000399A1 (en) * | 1988-07-08 | 1990-01-25 | Smithkline Beckman Corporation | Retroviral protease binding peptides |
| US5071837A (en) * | 1990-11-28 | 1991-12-10 | Warner-Lambert Company | Novel renin inhibiting peptides |
| DE69122266T2 (de) * | 1991-01-02 | 1997-03-27 | Merrell Pharmaceuticals Inc. (N.D.Ges.D. Staates Delaware), Cincinnati, Ohio | Antivirale verbindungen |
| HUT76648A (en) * | 1994-07-15 | 1997-10-28 | Merrell Pharma Inc | Difluorostatone, pharmaceutical compositions containing them and process for producing them |
-
1994
- 1994-11-28 KR KR1019960704227A patent/KR100367379B1/ko not_active Expired - Fee Related
- 1994-11-28 PT PT95903633T patent/PT742791E/pt unknown
- 1994-11-28 DE DE69426574T patent/DE69426574T2/de not_active Expired - Fee Related
- 1994-11-28 US US08/676,208 patent/US5969132A/en not_active Expired - Fee Related
- 1994-11-28 CA CA002182476A patent/CA2182476C/en not_active Expired - Fee Related
- 1994-11-28 NZ NZ277410A patent/NZ277410A/en unknown
- 1994-11-28 EP EP95903633A patent/EP0742791B1/en not_active Expired - Lifetime
- 1994-11-28 JP JP52059495A patent/JP3574455B2/ja not_active Expired - Fee Related
- 1994-11-28 AU AU12622/95A patent/AU684875B2/en not_active Ceased
- 1994-11-28 WO PCT/US1994/013711 patent/WO1995021186A1/en active IP Right Grant
- 1994-11-28 CN CN94194939A patent/CN1142830A/zh active Pending
- 1994-11-28 ES ES95903633T patent/ES2155515T3/es not_active Expired - Lifetime
- 1994-11-28 HU HU9602158A patent/HUT74384A/hu unknown
- 1994-11-28 AT AT95903633T patent/ATE198602T1/de not_active IP Right Cessation
- 1994-11-28 DK DK95903633T patent/DK0742791T3/da active
-
1995
- 1995-01-31 ZA ZA95756A patent/ZA95756B/xx unknown
- 1995-02-01 IL IL11251495A patent/IL112514A0/xx unknown
-
1996
- 1996-08-02 NO NO963254A patent/NO963254L/no not_active Application Discontinuation
- 1996-08-02 FI FI963073A patent/FI963073A0/fi not_active IP Right Cessation
-
2001
- 2001-03-23 GR GR20010400468T patent/GR3035623T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1142830A (zh) | 1997-02-12 |
| GR3035623T3 (en) | 2001-06-29 |
| US5969132A (en) | 1999-10-19 |
| ATE198602T1 (de) | 2001-01-15 |
| FI963073L (fi) | 1996-08-02 |
| KR100367379B1 (ko) | 2003-04-11 |
| DK0742791T3 (da) | 2001-04-02 |
| FI963073A0 (fi) | 1996-08-02 |
| JP3574455B2 (ja) | 2004-10-06 |
| NO963254D0 (no) | 1996-08-02 |
| HU9602158D0 (en) | 1996-09-30 |
| HUT74384A (en) | 1996-12-30 |
| IL112514A0 (en) | 1995-05-26 |
| EP0742791B1 (en) | 2001-01-10 |
| NZ277410A (en) | 1997-02-24 |
| NO963254L (no) | 1996-08-02 |
| DE69426574D1 (de) | 2001-02-15 |
| AU1262295A (en) | 1995-08-21 |
| CA2182476C (en) | 2000-12-26 |
| ZA95756B (en) | 1995-10-05 |
| AU684875B2 (en) | 1998-01-08 |
| DE69426574T2 (de) | 2001-08-09 |
| WO1995021186A1 (en) | 1995-08-10 |
| PT742791E (pt) | 2001-06-29 |
| JPH09508417A (ja) | 1997-08-26 |
| EP0742791A1 (en) | 1996-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2131589T3 (es) | Sulfonamidas inhibidoras de aspartil-proteasa del vih. | |
| MX9307821A (es) | Nueva clase de inhibidores de proteasa aspartilo. | |
| MX9403380A (es) | Inhibidores de proteasa de vih utiles para el tratamiento de sida. | |
| ES2181725T3 (es) | Inhibidores de hiv proteasa. | |
| ES2157437T3 (es) | Inhibidores de proteasas retrovirales de sulfonilalcanoilamino-hidroxietilamino-sulfonamida. | |
| ES2171670T3 (es) | Sulfonamidas que contienen heterociclos oxigenados como inhibidores de la aspartil proteasa. | |
| ES2177868T3 (es) | Hidroxietilaminosulfonamidas de alfa- y beta-aminoacidos utiles como inhibidores de proteasas retroviricas. | |
| CY1112632T1 (el) | Αναστολεις ασπαρτυλ πρωτεασης | |
| ES2182837T3 (es) | Piran-2-onas y 5,6-dihidropiran-2-onas utiles en el tratamiento del sida y de otros retrovirus. | |
| ES2052591T3 (es) | Variantes de virus lav, sus componentes de adn y de proteinas, y sus utilizaciones particularmente con fines diagnosticos y para la preparacion de composiciones inmunogenicas. | |
| ES2165269A1 (es) | Derivados de alfa-cetoamidas. | |
| ES2174921T3 (es) | Inhibidores de la proteasa del vih. | |
| ES2190793T3 (es) | Inhibidores de proteasas retrovirales de heterociclocarbonil aminoacido hidroxietilamino sulfonamida. | |
| ES2151600T3 (es) | Derivados de n-(3-amino-2-hidroxibutil)sulfonamida utilizados como inhibidores de proteasa de vih. | |
| ZA202306360B (en) | Substituted pyridotriazine compounds and uses thereof | |
| ES2095241T3 (es) | Secuencias oligonucleotidicas para la amplificacion del genoma de los retrovirus del tipo hiv-2 y siv, y sus aplicaciones al diagnostico in vitro de las infecciones debidas a estos virus. | |
| MX9700414A (es) | Agentes antivirales de difluoroestatona. | |
| ES2176263T3 (es) | 5,6-dihidropironas derivadas como inhibidores de proteasa y agentes antivirus. | |
| EA202191711A1 (ru) | Производные пиримидона в качестве селективных цитотоксических агентов против вич-инфицированных клеток | |
| ES2155515T3 (es) | Derivados de difluorostatona macrociclica utiles como agentes antivirales. | |
| ES2103577T3 (es) | Compuestos antiviricos de naftoquinona, composiciones que los contienen y utilizaciones de estos compuestos. | |
| MX2024010673A (es) | Compuestos antivirales y metodos de elaboracion y uso de los mismos. | |
| UA41338C2 (uk) | Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл) | |
| MX2022013814A (es) | Tratamiento de infecciones virales. | |
| ES2191095T3 (es) | Acidos tetronicos sustituidos utiles contra el vih y otros retrovirus. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 742791 Country of ref document: ES |